Biggest News Aggregation in the World
๐Ÿ“ฐ Wade Army News

Wade Army News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Wade Army. Real-time updates on events, politics, business and more.

Clinical trial may change the paradigm of care for patients with ALK-driven high-risk neuroblastoma

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children's Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.
United States United Kingdom Emily Henderson Yaelp Moss Kelly Goldsmith Baldrick Foundation

Researchers find lorlatinib to be safe and effective treatment for high-risk neuroblastoma

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Childrenโ€™s Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.
United States United Kingdom Yaelp Moss Kelly Goldsmith Children Neuroblastoma Cancer Foundation V Foundation For Cancer Research
Source: emory.edu

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science